Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Bexsero Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com

Bexsero Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Bexsero Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.

The Bexsero market has observed substantial growth, driven by various factors. Historically, these include meningococcal disease outbreaks, pediatric vaccination drives, and regulatory endorsements for group B vaccines. This growth is further propelled by public health awareness and government procurement schemes.

Looking forward, the expansion of adolescent vaccination programs, increased public health funding, and improved vaccine coverage are set to enhance market growth. Global immunization initiatives and outbreak preparedness strategies are also expected to play significant roles. Key trends include broadened meningococcal vaccination efforts, a focus on pediatric immunization, and government-led public health campaigns. Rising awareness of invasive meningococcal disease and integration into national immunization schedules further stimulate market development.

The increasing prevalence of meningitis is a critical driver for the future growth of the Bexsero market. With factors such as higher infection rates and improved detection systems contributing to this rise, Bexsero's role in protecting against meningitis by targeting Neisseria meningitidis group B bacteria is paramount. For instance, reports from the UK Health Security Agency in August 2024 highlighted an increase in invasive meningococcal disease cases, underscoring the vaccine's growing importance.

Research and development (R&D) activities are pivotal in supporting Bexsero market growth. R&D is fueled by the need for innovative solutions to combat emerging health challenges. Enhancing Bexsero's efficacy, safety, and applicability across diverse populations and new strains are key outcomes of ongoing research. Eurostat's report in July 2025 indicated a rise in EU government R&D allocations, emphasizing the sector's expansion.

Pharmaceutical leaders like GlaxoSmithKline (GSK) Plc are at the forefront of developing advanced meningococcal B vaccines. In July 2024, GSK launched Bexsero in South Korea, featuring a formulation that induces bactericidal antibodies against serogroup B antigens. This innovative approach aims to provide comprehensive protection.

North America leads the Bexsero market, with Asia-Pacific emerging as the fastest-growing region. The market includes diverse regions such as Western and Eastern Europe, North and South America, the Middle East, and Africa, with significant contributions from countries like the USA, China, and India.

Despite challenges posed by tariffs, which have increased manufacturing and distribution costs, domestic production and supply chain resilience have been bolstered. These tariffs have particularly affected public immunization programs in Europe and Asia-Pacific by influencing procurement budgets and logistics.

The Bexsero market is characterized by sales of various vaccines, including meningococcal and pneumococcal vaccines. The market analysis, capturing revenue data and geographical insights, provides a comprehensive view of the industry's current state and future prospects.

Bexsero, specifically developed to prevent invasive diseases caused by Neisseria meningitidis group B, plays a vital role in public health. It is administered to individuals from 2 months of age and distributed through diverse channels, serving a broad demographic.

Key Topics Covered:

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Bexsero Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Bexsero Market Attractiveness Scoring and Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Bexsero Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List of Key Raw Materials, Resources & Suppliers

3.3. List of Major Distributors and Channel Partners

3.4. List of Major End Users

4. Global Bexsero Market Trends and Strategies

4.1. Key Technologies & Future Trends

4.2. Major Trends

5. Bexsero Market Analysis of End Use Industries

5.1 Hospitals

5.2 Public Health Clinics

5.3 Pediatric Clinics

5.4 Vaccination Centers

5.5 School Health Programs

6. Bexsero Market - Macro Economic Scenario

7. Global Bexsero Strategic Analysis Framework

7.1. Global Bexsero PESTEL Analysis

7.2. Global Bexsero Market Size, Comparisons and Growth Rate Analysis

7.3. Global Bexsero Historic Market Size and Growth, 2020-2025, Value ($ Billion)

7.4. Global Bexsero Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)

8. Global Bexsero Total Addressable Market (TAM) Analysis

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bexsero Market Segmentation

9.1. Global Bexsero Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.2. Global Bexsero Market, Segmentation by Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

9.3. Global Bexsero Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10. Bexsero Market Regional and Country Analysis

10.1. Global Bexsero Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Bexsero Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/kxki5q

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.